期刊文献+

血清谷氨酰转肽酶对慢性重型肝炎预后判断的价值 被引量:2

Serum γ-glutamyl transferase values predict prognosis of chronic severe hepatitis
下载PDF
导出
摘要 目的探讨血清γ-谷氨酰转肽酶(γ-glutamyl transferase,GGT)对慢性重型乙型肝炎预后判断的价值。方法测定56例慢性重型乙型肝炎病人血清SB、PT、Cr、ALP、GGT水平,同时计算出56例病人的终末期肝病模型(model for end-stage liver disease,MELD)分值,分析存活组和死亡组GGT、MELD以及二者之间的关系。结果存活组GGT值为(121.7±68.1)U/L,死亡组GGT值为(34.7±34.9)U/L,(t=3.25,P〈0.01);存活组MELD值为(19.2±12.1),死亡组MELD分值为(28.8±11.9),(t=2.5,P〈0.05)。56例GGT值为(77.2±68.3)U/L,MELD分值为(23.2±11.5),二者呈负相关(r=-0.34,P〈0.05)。慢性重型乙型肝炎肝性脑病合并肝肾综合征以及肝性脑病合并上消化道出血两组比较,GGT值无显著差异(P〉0.05),MELD分值有非常显著差异(P〈0.001)。结论GGT是判断重型肝炎预后的一个有意义的指标。 Objective To explore predictive factors for the prognosis of chronic severe hepatitis. Methods Serum total bilirubin (TB), prothrombin time (PT), creatinine (Cr), alanine aminotransferase (ALT), and γ-glutamyl transferase (GGT) were detected and an MELD score was calculated in 56 patients with chronic severe hepatitis. The GGT value, the MELD score and their correlations in survival and death groups were analyzed. Results The GGT value in the survival (121.7±68.1) group was significantly higher than that in the death group (34.7±34.9) (t=-3.25, P〈0.01). In contrast, the MELD score in the survival group (19.2±12.1) was significantly lower than that in the death group (28.8±11.9) (t=-2.5, P〈0.05). There was an evidently negative correlation between the GGT value and the MELD score (r=-0.679, P〈0.01). No GGT score different was noticed between hepatorenal syndrome with hepatic encephalopathy group and upper gastrointestinal bleeding with hepatic encephalopathy group; however, a significant difference in the MELD score was noticed between them. Conclusion Serum γ-glutamyl transferase is a useful predictor for the prognosis of chronic severe hepatitis.
出处 《世界感染杂志》 2005年第4期330-332,共3页 World Journal of Infection
  • 相关文献

参考文献5

二级参考文献14

  • 1骆抗先.乙型肝炎-基础和临床(第1版)[M].北京:人民卫生出版社,1996.51-270.
  • 2Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg, 1973, 60:646-649.
  • 3Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child- Turcotte criteria in medically treated cirrhosis. Hepatology,1984, 4: 430-435.
  • 4Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987, 7: 660-664.
  • 5Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 2000, 31: 864-871.
  • 6Arroyo V, Gines P, Gerbes AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis.Hepatology, 1996, 23: 164-176.
  • 7Robert A, Chazouilleres O. Prothrombin time in liver failure: time,ratio, activity percentage or international normalized ratio?Hepatology, 1996, 24: 1392-1394.
  • 8Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from Child to MELD. Hepatology, 2001, 33:473-475.
  • 9McCaughan GW, Strasser SI. To MELD or not to MELD?Hepatology, 2001, 34: 215-216.
  • 10Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003,52: 134-139.

共引文献14084

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部